Identification of treatments targeting PMLexpressing breast cancers
Laburpena
The main aim of this project is to find a suitable ATO concentration to combine with already approved
chemotherapeutic agents to find that synergistic effect in triple negative breast cancer MDA-MB 231
cell line, as a new strategy to treat the disease.